FMci-Family Medicine - Common Issues: COPD; Hypertension; Endocrine Disorders

FMci-Family Medicine - Common Issues: COPD; Hypertension; Endocrine Disorders is organized by American Medical Seminars (AMS), Inc. This course has been approved for a maximum of 5 AMA PRA Category 1 Credits.

Original Release Date: July 1, 2020  
Expiration Date: July 1, 2023

TOPIC 1: Chronic Obstructive Pulmonary Disease (COPD): Evaluation and Treatment:
Upon completion of this session, using the ACCP GOLD guidelines, the AACVPR practice guidelines, and the evidence-based reports from Clinical Evidence, the participant should be able to: EBM, GL, COMP
• Appraise patient-specific data to determine if they meet diagnostic criteria for COPD.
• Analyze the role of cigarette smoking in the etiology and natural history of COPD.
• Formulate a treatment plan for the stages of COPD.
• Recommend the follow-up required to assess the therapeutic efficacy of the treatment options.

TOPIC 2: Evaluation and Treatment of Hypertensive Patients:
Upon completion of this session, using the most recent JNC Guidelines, the Cochrane Abstract Database, and the evidence-based reports from Clinical Evidence, the participant should be able to: EBM, GL, COMP
• Employ non-pharmacologic treatment options to manage hypertension.
• Specify the pharmacologic treatment options for patients with compelling indications based upon JNC Guidelines.
• Formulate the therapeutic goal for controlling blood pressure in different patient populations and the combination of medications that can achieve that goal.
• Distinguish the side effect risks for each class of antihypertensive medications.

TOPIC 3: Common Endocrine Disorders:
Upon completion of this session, the participant should be able to: EBM, GL, COMP
• Recognize, evaluate, and treat common endocrine abnormalities and employ Endo Society Guidelines to include:
• Hypoglycemia,
• Hypercalcemia,
• Low testosterone,
• Adrenal masses.